Navigation Links
Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Date:8/25/2009

uld have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

    CONTACT: Amgen, Thousand Oaks
    Emma Hurley: 805-447-7845 (media)
    Arvind Sood: 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
2. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
3. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
6. Medarex to Receive Milestone Payment from Amgen
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
10. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
11. Bionovo Announces Second Quarter 2009 Highlights and Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... 19 In response to an ever-increas...egal medicines, Operation Pangea II, involving 24 ...ld Health Organization,s International Medical Pro...ghlight the dangers of buying medicines online. ,...series of arrests and the seizure of thousands of ...
(Date:11/19/2009)...19 Riverain Medical announced toda... Canadian medical imaging distributor Christie Gro...Guard Chest Xray CAD. The exclusive agreement will...cts to the Canadian market through Christie Group,...oftView Enhanced Chest Imaging increases the clari...
(Date:11/19/2009)...ational Internet Week of Action ,, SILVER SPRI...S. Food and Drug Administration today completed a ...d the International Internet Week of Action (IIWA)...al products. ,, (Logo: http://www.newscom.com/...ffort, the FDA,s Office of Criminal Investigations...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 1Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 2Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 3ADHD Drugs Linked to Sudden Death in Kids 48862 1ADHD Drugs Linked to Sudden Death in Kids 48862 2ADHD Drugs Linked to Sudden Death in Kids 48862 3Dr Dean Dornic Certified to Perform Artificial Cornea Transplant 48859 1Dr Dean Dornic Certified to Perform Artificial Cornea Transplant 48859 2Dr Dean Dornic Certified to Perform Artificial Cornea Transplant 48859 3
..., 2007 /PRNewswire/ -- CSL Limited today,announced...the,American Medical Association that suggest infu...se HDL ("good" cholesterol) levels,may reduce the...ents with a recent episode of acute coronary syndr...able angina and myocardial,infarction (heart attac...
...esented at Keystone Scientific Meeting, SOUTH SAN ...tCall/ -- Rigel today announced that Yonchu,Jenkin...presenting,on the company,s efforts to develop a s...he Human Immunodeficiency Virus (HIV),infection at...ch,27th and 29th. Dr. Jenkins will present both a ...
Other Medicine Technology:CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 2CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 3CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries 4Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3
(Date:11/20/2009)...N, N.J., Nov. 20 Rates o...ave peaked in late October, but the pandemic flu v... in all age groups, including the elderly, accordi...ed (NYSE: DGX ), the world,s leading provider of..., In its most recent Quest Diagnostics Health Tr...
(Date:11/20/2009)...ALEM, N.C., Nov. 20 Sam... to redefine what it means to be "happy" during th...ith a specialty in family counseling and chair of ...sity, Gladding says research shows that it is the ...nd even depression during the holidays. ,, That...
(Date:11/20/2009)...exposure to formaldehyde used for embalming in the...d risk of death from myeloid leukemia, according t... Journal of the National Cancer Institute . , Pr...mphohematopoietic malignancies and brain cancer in...rkers, all of whom may have worked with formaldehy...
(Date:11/20/2009)...s short as 34 weeks, potentially adding to preemie...Nov. 20 (HealthDay News) -- Recent reports show th...mb in the United States. Now, a new study suggest...at constitutes a full-term birth in the first plac...in the study considered a baby born at 34 to 36 we...
(Date:11/20/2009)... Longtime OB/GYN warns against the new breast...ntative Services Task Force. These guidelines may ...uman lives. When is it wrong to be safe than sorry...tive Services Task Force recommendations, publishe...edicine, has set off a firestorm in the medical co...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
...stantiated in yesterday’s ruling by the Sheriff, c.../ measures to a lady patient who had suffered a la...e lady might have survived, had she been referred ...ce of the staff at St John's Hospital in Livingsto...
...5,700 to a clinic here that supports refugee women..., in Australian dollars, was announced Thursday by...Vanstone. "The donation again demonstrates t...will be providing these women with a safe and secu...
... manipulation appears of little use as per a study...the UK to relieve many different types of pain,// .... When 16 studies were reviewed it was conclu...osteopaths and chiropractors. Professor Edzard Er...
...e meaning of ‘dirty’, then, visit New York. It wo...ng well known// for its cancer causing air, accord...cy. New York had some stiff competition fro...dings have taken into account emissions of 177 che...
...on (WHO), there is an outbreak of apparent botulis...reserved// bamboo shoots. It has left more than 1.... WHO further stated that according to the Thai Mi...n almost 40 of them in need of respirators, though...
...ucted by the University of Wisconsin Madison Cente...(CECCR) found// that Women suffering from breast c...were given the opportunity to participate in onlin...riences. Bret Shaw, who is the lead author o...
Other Medicine News:Health News:Research demystifies treatment by manipulation of spine by chiropractors in the UK 2Health News:Bamboo Shoots Causes Botulism Outbreak 2Health News:Study Finds Online Support Groups Emotionally Benefit Women Suffering From 2
...on the solid, tested XiIIIPlus platform, the R170X...evel of on-demand printing flexibility in tag plac...eamless integration into enterprise systems, autom...iple power levels, statistics tracking, easier RFI...
...on the solid, tested XiIIIPlus platform, the R110X...vel of on-demand printing flexibility in tag place...amless integration into enterprise systems, automa...ple power levels, statistics tracking, easier RFID...
Zebra 90xiIII Printers
Zebra 105SL Cutting Edge Barcode Printer Network Connectivity
Medicine Products: